You are now leaving GSK Malta Health Portal

You are about to leave a GSK Website. By clicking this link, you will be taken to an external website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on this site. If you do not wish to leave this website, click on “Go Back” below:

Continue

Go back

MLT_GIB/OTH/0007/17m
Date of preparation: March 2018

Relvar Ellipta Dosing & Administration

Relvar is available in the Ellipta, an easy-to-use inhaler that helps your patients receive the benefit of their asthma and COPD medication. 12

Click on the icon to find out more about the Ellipta 

See how easy the Ellipta device is to use

 

Dosing for patients with asthma and COPD

Asthma 3
Adults and adolescents ≥ 12 years who require a low to mid dose ICS/LABA One inhalation of Relvar Ellipta 92/22 mcg once daily
Adults and adolescents ≥ 12 years who require a higher dose ICS/LABA One inhalation of Relvar Ellipta 184/22 mcg once daily
The maximum recommended dose is one inhalation of Relvar Ellipta 184/22 mcg once daily
COPD 3
For patients with COPD One inhalation of Relvar Ellipta 92/22 mcg once daily

 

Dosing adjustments in asthma and COPD

There is no need to adjust dose for elderly patients, or for those with renal impairment. 3

Exercise caution for patients with hepatic impairment. They may be more at risk of systemic adverse reactions associated with corticosteroids.

For patients with moderate or severe hepatic impairment, the maximum dose is 92/22 mcg.Please see Relvar SPC for more detail  3

Relvar Ellipta administration

Relvar Ellipta is for inhalation only. It should be administered at the same time every day. 3

Read on for a step-by-step guide to administering Relvar Ellipta. 3

  • 1.How to prepare a dose:

    • Open the cover. Do not shake the inhaler. Slide down the cover until you hear a ‘click’
       

    2.How to inhale the medicine:

    • Hold the inhaler away from your mouth and breathe out as far as comfortable. Do NOT breathe out into the inhaler
    • Put the mouthpiece between your lips and close your lips firmly around it
    • Do not block the air vents with your fingers
    • Take one long, steady, deep breath in. Hold it for as long as possible (at least 3–4 seconds)
    • Remove the inhaler from your mouth
    • Breathe out slowly and gently

    3.Close the inhaler. :

    • If you want to clean the mouthpiece, use a dry tissue before closing the cover.
    • Slide the cover upwards as far as it will go to cover the mouthpiece.

    4.Rinse your mouth:

    • If your patient rinses his/her mouth with water after they have used the inhaler, it is less likely they will develop a sore mouth or throat as side effects.

 

Product storage 3

  • Do not store above 25°C
  • If stored in a refrigerator, allow the inhaler to return to room temperature for at least 1 hour before use
  • Use within 6 weeks of first opening the tray – as soon as the inhaler is removed from the tray, write the date on which it should be discarded in the space provided on the label 

References

  1. Riley JH et al. Correct usage ease of use and preference of two dry powder inhalers in patients with COPD analysis of five phase III randomized trials. Int J Chron Obstruct Pulmon Dis. 2016; 21: 1873–1880.
  2. van der Palen et al. A randomised open-label cross-over study of inhaler errors, preference and time to achieve correct inhaler use in patients with COPD or asthma: comparison of Ellipta with other inhaler devices. Primary Care Resp Med 2016;26: 16079; doi:10.1038/npjpcrm.2016.79.
  3. Relvar Ellipta Summary of Product Characteristics, GlaxoSmithKline.

Relvar and Ellipta are trademarks of the GSK group of companies.